Tag: BASIL 3
Vascular Specialist–May 2024
In this issue:
Questions linger: BASIL-3 does not find for drug-eluting technologies for CLTI
Guest Editorial: Aortas, open surgical skills and gratitude
Vascular training:...
Questions linger: BASIL-3 does not find for drug-eluting technologies for CLTI
In the UK National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA)-funded BASIL-3 randomised controlled trial (RCT), neither drug-coated balloon (DCB)...
Vascular Specialist–April 2024
In this issue:
Bad reading: Worrying new data demonstrate a consistent shortfall of more than a fifth in net revenues over a four-year period...
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data...
At the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK), Andrew Bradbury (University of Birmingham, Birmingham, UK) and the BASIL-3 team of triallists...